468 related articles for article (PubMed ID: 25106636)
1. Neuroprotection by association of palmitoylethanolamide with luteolin in experimental Alzheimer's disease models: the control of neuroinflammation.
Paterniti I; Cordaro M; Campolo M; Siracusa R; Cornelius C; Navarra M; Cuzzocrea S; Esposito E
CNS Neurol Disord Drug Targets; 2014; 13(9):1530-41. PubMed ID: 25106636
[TBL] [Abstract][Full Text] [Related]
2. A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury.
Paterniti I; Impellizzeri D; Di Paola R; Navarra M; Cuzzocrea S; Esposito E
J Neuroinflammation; 2013 Jul; 10():91. PubMed ID: 23880066
[TBL] [Abstract][Full Text] [Related]
3. The Association of Palmitoylethanolamide with Luteolin Decreases Neuroinflammation and Stimulates Autophagy in Parkinson's Disease Model.
Siracusa R; Paterniti I; Impellizzeri D; Cordaro M; Crupi R; Navarra M; Cuzzocrea S; Esposito E
CNS Neurol Disord Drug Targets; 2015; 14(10):1350-65. PubMed ID: 26295827
[TBL] [Abstract][Full Text] [Related]
4. Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α.
Scuderi C; Valenza M; Stecca C; Esposito G; Carratù MR; Steardo L
J Neuroinflammation; 2012 Mar; 9():49. PubMed ID: 22405189
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective Effects of Co-UltraPEALut on Secondary Inflammatory Process and Autophagy Involved in Traumatic Brain Injury.
Cordaro M; Impellizzeri D; Paterniti I; Bruschetta G; Siracusa R; De Stefano D; Cuzzocrea S; Esposito E
J Neurotrauma; 2016 Jan; 33(1):132-46. PubMed ID: 25046306
[TBL] [Abstract][Full Text] [Related]
6. Co-ultramicronized Palmitoylethanolamide/Luteolin in the Treatment of Cerebral Ischemia: from Rodent to Man.
Caltagirone C; Cisari C; Schievano C; Di Paola R; Cordaro M; Bruschetta G; Esposito E; Cuzzocrea S;
Transl Stroke Res; 2016 Feb; 7(1):54-69. PubMed ID: 26706245
[TBL] [Abstract][Full Text] [Related]
7. Looking for a Treatment for the Early Stage of Alzheimer's Disease: Preclinical Evidence with Co-Ultramicronized Palmitoylethanolamide and Luteolin.
Facchinetti R; Valenza M; Bronzuoli MR; Menegoni G; Ratano P; Steardo L; Campolongo P; Scuderi C
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471239
[TBL] [Abstract][Full Text] [Related]
8. Luteolin Inhibits Fibrillary β-Amyloid
Zhang JX; Xing JG; Wang LL; Jiang HL; Guo SL; Liu R
Molecules; 2017 Feb; 22(3):. PubMed ID: 28245546
[TBL] [Abstract][Full Text] [Related]
9. The Association of Palmitoylethanolamide with Luteolin Decreases Autophagy in Spinal Cord Injury.
Siracusa R; Paterniti I; Bruschetta G; Cordaro M; Impellizzeri D; Crupi R; Cuzzocrea S; Esposito E
Mol Neurobiol; 2016 Aug; 53(6):3783-3792. PubMed ID: 26143261
[TBL] [Abstract][Full Text] [Related]
10. Deciphering the Potential Neuroprotective Effects of Luteolin against Aβ
Ahmad S; Jo MH; Ikram M; Khan A; Kim MO
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502488
[TBL] [Abstract][Full Text] [Related]
11. Neuroglial roots of neurodegenerative diseases: therapeutic potential of palmitoylethanolamide in models of Alzheimer's disease.
Scuderi C; Steardo L
CNS Neurol Disord Drug Targets; 2013 Feb; 12(1):62-9. PubMed ID: 23394526
[TBL] [Abstract][Full Text] [Related]
12. Association of Neuroprotective Effect of Di-O-Demethylcurcumin on Aβ25-35-Induced Neurotoxicity with Suppression of NF-κB and Activation of Nrf2.
Pinkaew D; Changtam C; Tocharus C; Govitrapong P; Jumnongprakhon P; Suksamrarn A; Tocharus J
Neurotox Res; 2016 Jan; 29(1):80-91. PubMed ID: 26358194
[TBL] [Abstract][Full Text] [Related]
13. Anti-Inflammatory and Neuroprotective Effects of Co-UltraPEALut in a Mouse Model of Vascular Dementia.
Siracusa R; Impellizzeri D; Cordaro M; Crupi R; Esposito E; Petrosino S; Cuzzocrea S
Front Neurol; 2017; 8():233. PubMed ID: 28634464
[TBL] [Abstract][Full Text] [Related]
14. Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression.
Esposito G; Scuderi C; Savani C; Steardo L; De Filippis D; Cottone P; Iuvone T; Cuomo V; Steardo L
Br J Pharmacol; 2007 Aug; 151(8):1272-9. PubMed ID: 17592514
[TBL] [Abstract][Full Text] [Related]
15. PEA and luteolin synergistically reduce mast cell-mediated toxicity and elicit neuroprotection in cell-based models of brain ischemia.
Parrella E; Porrini V; Iorio R; Benarese M; Lanzillotta A; Mota M; Fusco M; Tonin P; Spano P; Pizzi M
Brain Res; 2016 Oct; 1648(Pt A):409-417. PubMed ID: 27423516
[TBL] [Abstract][Full Text] [Related]
16. Astrocytic palmitoylethanolamide pre-exposure exerts neuroprotective effects in astrocyte-neuron co-cultures from a triple transgenic mouse model of Alzheimer's disease.
Beggiato S; Cassano T; Ferraro L; Tomasini MC
Life Sci; 2020 Sep; 257():118037. PubMed ID: 32622942
[TBL] [Abstract][Full Text] [Related]
17. Palmitoylethanolamide Regulates Production of Pro-Angiogenic Mediators in a Model of β Amyloid-Induced Astrogliosis In Vitro.
Cipriano M; Esposito G; Negro L; Capoccia E; Sarnelli G; Scuderi C; De Filippis D; Steardo L; Iuvone T
CNS Neurol Disord Drug Targets; 2015; 14(7):828-37. PubMed ID: 25801844
[TBL] [Abstract][Full Text] [Related]
18. N-Palmitoylethanolamine-Oxazoline as a New Therapeutic Strategy to Control Neuroinflammation: Neuroprotective Effects in Experimental Models of Spinal Cord and Brain Injury.
Impellizzeri D; Cordaro M; Bruschetta G; Siracusa R; Crupi R; Esposito E; Cuzzocrea S
J Neurotrauma; 2017 Sep; 34(18):2609-2623. PubMed ID: 28095731
[TBL] [Abstract][Full Text] [Related]
19. Palmitoylethanolamide Blunts Amyloid-β42-Induced Astrocyte Activation and Improves Neuronal Survival in Primary Mouse Cortical Astrocyte-Neuron Co-Cultures.
Beggiato S; Borelli AC; Ferraro L; Tanganelli S; Antonelli T; Tomasini MC
J Alzheimers Dis; 2018; 61(1):389-399. PubMed ID: 29154284
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
Wu X; Kosaraju J; Zhou W; Tam KY
ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
